PASS of Paediatric Patients Initiating Selumetinib

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Country	Location
Austria	Wien, Austria
France	Amiens, France
France	Angers, France
France	Bordeaux, France
France	Lille, France
France	Lyon, France
France	Marseille, France
France	Paris, France
France	STRASBOURG, France
France	Toulouse, France
France	Tours, France
France	Villejuif Cedex, France
Germany	Duisburg, Germany
Germany	Hamburg, Germany
Germany	München, Germany
Germany	Tubingen, Germany
Israel	Petach Tikva, Israel
Israel	Ramat Gan, Israel
Italy	Firenze, Italy
Italy	Genova, Italy
Italy	Milano, Italy
Italy	Padova, Italy
Italy	Pavia, Italy
Italy	Roma, Italy
Italy	Torino, Italy
Italy	Trieste, Italy
Portugal	Lisboa, Portugal
Portugal	Porto, Portugal
Spain	Barcelona, Spain
Spain	Esplugues de Llobregat, Spain
Spain	Madrid, Spain
Spain	Santiago de Compostela, Spain
Spain	Sevilla, Spain
Switzerland	Basel, Switzerland
Switzerland	Bern, Switzerland
Switzerland	Lausanne, Switzerland
Switzerland	St. Gallen, Switzerland
UK	Manchester, UK
United Kingdom	London, United Kingdom